Good morning, everyone, and nice to see you again. We hope the weekend was refreshing. Now, of course, the routine of meetings and deadlines returns. And there are plenty this week. We know you can relate. So please join us as we reach for that mandatory cup of stimulation and peruse the news of the world. Have a great day and catch you later...
Supreme Court Won't Consider Zyprexa Lawsuit Against Lilly (Dow Jones)
Bristol & AstraZeneca Diabetes Med Shows Cancer Risks (Bloomberg News)
Big Retailers Hike Prices For Brand-Name Diabetes Meds (Reuters)
NY Senator Calls For Crackdown On Prescription Painkiller Abuse (CBS News)
Genentech Strikes An Alliance For Early-Stage Cancer Drug (Xconomy)
Abbott Drug Reverses Kidney Decline In Diabetics: Study (Bloomberg News)
Avandia And Actos Raise Risk Of Eye Disease (Bloomberg News)
EMA's CHMP Recommends Novartis And Boehringer Drugs (Pharma Times)
Bydureon Study Shows Tiny Link To Changes In Heart Rhythms (Reuters)
Generic AIDS Drugs Can Cause Premature Aging: Study (MSNBC)
Glenmark Receives $25M Upfront Payment From Sanofi (Economic Times)
EDITOR’S NOTE: Please check this post for updates throughout the morning